Compare DexCom, Inc. (DXCM) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Star Bulk Carriers Corp — how do they compare? DexCom, Inc. trades at $77.86 (market cap $28.06B), while Star Bulk Carriers Corp trades at $26.51 (market cap $2.94B). The key difference: DexCom, Inc. is far larger — about 9.5× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.91% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SBLK | |
|---|---|---|
Market Cap | $28.06B | $2.94B |
Sector | Health | Industrials |
52-Week High | $89.53 | $28.21 |
52-Week Low | $54.84 | $16.79 |
Enterprise Value | $27.03B | $3.64B |
Dividend Yield | — | 3.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Star Bulk Carriers (SBLK) trades at $26.50, showing modest daily weakness with a 0.23% decline. The stock maintains a bullish technical outlook with strong moving average support, while recent earnings beats in Q4 2025 and Q1 2026 demonstrate operational strength. The company's modernizing fleet and dividend policy supporting yields above 10% provide attractive shareholder returns amid favorable dry bulk shipping rates.
SBLK presents compelling value with improving fundamentals and analyst optimism, though investors face risks from shipping rate volatility and cyclical industry exposure. The 58% buy rating consensus and projected profit margin expansion to 13% support upside potential, balanced by the need to monitor Q2 2026 earnings delivery against high expectations of $0.96 EPS.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
